The South Korean pharmaceutical company, GL Rapha, has confirmed that it will start commercial supplies of the Russian “Sputnik V” vaccine to the United Arab Emirates in late February.
The press office of the Korean company said in an interview with Russian Sputnik news agency, on Friday: “We received a response that there are no problems in general.
We are currently working on cell culture, that is, the raw material for industrial scale production. We have agreed that Russian experts will arrive from Gamalia in early February”.
“We will monitor operations together, and according to our estimates, we will supply the first batch in late February or early March”.
He added that the first 150 million doses of the vaccine, which will be produced by the company, were reserved by the UAE, but the producer may supply the vaccine to other countries as well or to Russia in the event of a request by the Russian Fund for Direct Investments.
The company added that the demand for the Russian vaccine around the world may exceed the 350 million doses, which the Russian Direct Investment Fund plans to produce annually abroad.